The Presentation of Self-Peptides: Tolerance and Competition

References

• Kourilsky P., Chaouat G., Rabourdin-Combe C., Claverie J. Working principles in the immune system implied by the “peptidic self” model. Proc. Natl. Acad. Sci. USA 1987; 84: 3400–3404
   PubMed Web of Science ®Google Scholar
• Lee P., Matsueda G. R., Allen P. M. T cell recognition of fibrinogen: A determinant on the Aα-chain does not require processing. J. Immunol. 1988; 140: 1063–1068
   PubMedGoogle Scholar
• Sette A., Adorini L., Colon S. M., Buus S., Grey H. M. Capacity of intact proteins to bind to MHC class II molecules. J. Immunol. 1989; 143: 1265–1267
   PubMed Web of Science ®Google Scholar
• Shastri N., Miller A., Sercarz E. E. The expressed T cell repertoire is hierarchical: the precise focus of lysozyme-specific T cell clones is dependent upon the structure of the immunogen. J. Mol. Cell Immunol. 1985; 1: 369–377
   Google Scholar
• Cogswell J. P., Gammon G., Wilbur S., Shastri N., Miller A., Sercarz E. E. La dependent selection of agretopes on the partially unfolded chicken lysozyme molecule affects subsequent processing pathways and the dominance of T cell determinants. Antigen Presenting Cells, L. B. Schook. Alan R. Liss, Inc., New York 1988; 115–126
   Google Scholar
• Sercarz E. E. The architectonics of immune dominance: The aleatory effects of molecular position on the choice of antigenic determinants. Chemical Immunology: Antigenic Determinants and Immune Regulation. Karger, Basel 1989; Vol. 46: 169–185
   Google Scholar
• Katz M., Maizels R., Wicker L., Miller A., Sercarz E. E. Immunological focusing by the mouse MHC: mouse strains confronted with distantly related lysozymes confine their attention to very few epitopes. Eur. J. Immunol. 1982; 12: 535–540
   Google Scholar
• Adorini L., Appella E., Doria G., Nagy Z. A. Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 1988; 168: 2091–2104
   PubMedGoogle Scholar
• Demotz S., Grey H. M., Appella E., Sette A. Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme. Nature 1989; 342: 682–684
   PubMedGoogle Scholar
• Sercarz E., Wilbur S., Sadegh-Nasseri S., Miller A., Manca F., Gammon G., Shastri N. The molecular context of a determinant influences its dominant expression in a T cell response hierarchy through “fine processing.”. Progress in Immunology VI: Sixth International Congress of Immunology. 1986; Vol. 6: 227–237
   Google Scholar
• Shastri N., Gammon G., Horvath S., Miller A., Sercarz E. E. The choice between two distinct T cell determinants within a 23 amino acid region of lysozyme depends upon structure of the immunogen. J. Immunol. 1986; 137: 911–915
   PubMedGoogle Scholar
• Gammon G., Sercarz E. E. How some T-cells escape tolerance induction. Nature 1989; 342: 183–185
   PubMedGoogle Scholar
• Gammon G., Shastri N., Cogswell J., Wilbur S., Sadegh-Nasseri S., Krzych U., Miller A., Sercarz E. E. The choice of T cell epitopes utilized on a protein antigen depends on factors distant from, as well as at, the determinant site. Immunol. Rev. 1987; 98: 53–73
   PubMed Web of Science ®Google Scholar
• Gammon G., Dunn K., Shastri N., Oki A., Wilbur A., Sercarz E. E. Neonatal T cell tolerance to minimal immunogenic peptides is due to clonal inactivation. Nature 1986; 319: 413–415
   PubMed Web of Science ®Google Scholar
• Ria F., Chan B. M. C., Scherer M. T., Smith J. A., Gefter M. L. Immunological activity of covalently linked T-cell epitopes. Nature 1990; 343: 381–383
   PubMed Web of Science ®Google Scholar
• Clayton J. P., Gammon G. M., Ando D. G., Kono D. H., Hood L., Sercarz E. E. Peptide specific prevention of experimental allergic encephalomyelitis: Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp. Med. 1989; 169: 1681–1691
   PubMedGoogle Scholar
• Kumar V., Urban J. L., Horvath S. J., Hood L. Amino acid variations at a single residue in an autoimmune peptide profoundly affect its properties: T-cell activation, major histocompatibility complex binding, and ability to block experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA 1990; 87: 1337–1341
   PubMedGoogle Scholar
• Wraith D. C., Smilek D. E., Mitchell D. J., Steinman L., McDevitt H. O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 1989; 59: 247–255
   PubMed Web of Science ®Google Scholar
• Ametani A., Apple R., Bhardwaj V., Gammon G., Miller A., Sercarz E. E. Examining the crypticity of antigenic determinants. Cold Spring Harbor, Symposia on Quantitative Biology 1989; 54: 505–512
   Google Scholar
• Sercarz E. E., Krzych U. T suppressor cell-inducing determinants. Immunol. Today 1990, Submitted
   Google Scholar
• Jensen P. E., Kapp J. A., Pierce C. W. The role of suppressor T cells in the expression of immune response gene function. J. Mol. Cell. Immunol. 1987; 3: 267–275
   PubMedGoogle Scholar
• Sercarz E. Ir gene regulation: Past failures to present cogent mechanisms and to delete diverting oversimplifications. J. Mol. Cell. Immunol. 1987; 3: 277–278
   Google Scholar
• Lider O., Santos L. M. B., Lee C. S. Y., Higgins P. J., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. J. Immunol. 1989; 142: 748–752
   PubMed Web of Science ®Google Scholar
• Townsend A. R. M., Rothbard J., Gotch F., Bahadur G., Wraith D., McMichael A. J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986; 44: 959–968
   PubMed Web of Science ®Google Scholar
• Babbitt B. P., Allen P. M., Matsueda G., Haber E. P., Unanue E. R. The binding of immunogenic peptides to la histocompatibility molecules. Nature 1985; 317: 359–361
   PubMed Web of Science ®Google Scholar
• Buus S., Colon S., Smith C., Freed J. H., Miles C., Grey H. M. Interaction between a “processed” ovalbumin peptide and la molecules. Proc. Natl. Acad. Sci. USA 1986; 83: 3968–3971
   PubMed Web of Science ®Google Scholar
• Lorenz R. G., Allen P. M. Direct evidence for functional self-protein/la-molecule complexes in vivo. Proc. Natl. Acad. Sci. USA 1988; 85: 5220–5223
   PubMed Web of Science ®Google Scholar
• Nuchtern J. G., Biddison W. E., Klausner R. D. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 1990; 343: 74–76
   PubMed Web of Science ®Google Scholar
• Saskia de Koster H., Anderson D. E., Termitjelen A. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J. Exp. Med. 1989; 169: 1191–1196
   Google Scholar
• Benichou G., Ho P. T., Takizawa P. A., Killion C. C., Olson C. A., McMillan M., Sercarz E. E. Immunogenicity and tolerogenicity of self-MHC peptides. 1990, Submitted
   Google Scholar
• Stockinger B., Lin R. H. An intracellular self protein synthesized in macrophages is presented but fails to induce tolerance. Int. Immunol. 1989; 1: 592–597
   Google Scholar
• Murphy D. B., Lo D., Rath S., Brinster R. L., Flavell R. A., Slanetz A., Janeway C. A., Jr. Differential expression of a novel MHC class II epitope in the thymus. Immunogenicity, C. A. Janeway, Jr., J. Sprent, E. E. Sercarz. UCLA Symposia on Molecular and Cellular Biology, New Series, vol. 113, Wiley-Liss, New York 1990; 17–26
   Google Scholar
• Snell G. D. Studies in histocompatibility. Science 1981; 213: 172–178
   PubMed Web of Science ®Google Scholar
• Dausset J. The major histocompatibility complex in man. Science 1981; 213: 1469–1474
   PubMedGoogle Scholar
• Matzinger P., Bevan M. Why so many lymphocytes respond to major histocompatibility antigens?. Cell. Immunol. 1977; 29: 1–5
   PubMed Web of Science ®Google Scholar
• Pierres M., Marchetto S., Naquet P. M., Landais D., Peccoud J., Benoist C., Mathis D. I-A alpha polymorphic residues that determine alloreactive T cell recognition. J. Exp. Med. 1989; 169: 1655–1668
   Google Scholar
• Maryanski J. L., Pola P., Corradin G., Jordan B. R., Cerottini J. C. H-2 restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature 1986; 324: 578–579
   PubMed Web of Science ®Google Scholar
• Heath W. R., Hurd M. E., Carbone F. R., Sherman L. A. Peptide-dependent recognition of H-2 Kb by alloreactive cytotoxic T lymphocytes. Nature 1989; 341: 749–752
   Google Scholar
• Parham P., Clayberger C., Zorn S. L., Ludwig D. S., Schoolnik G. K., Krensky A. M. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature 1987; 325: 625–628
   PubMed Web of Science ®Google Scholar
• Song E. S., Linsk R., Olson C. A., McMillan M., Goodenow R. S. Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecules. Proc. Natl. Acad. Sci. USA 1988; 85: 1927–1931
   PubMed Web of Science ®Google Scholar
• Singer A., Munitz T. I., Golding H., Rosenberg A. S., Mizuochi T. Recognition requirements for the activation, differentiation and function of T-helper cells specific for class I MHC alloantigens. Immunol. Rev. 1987; 98: 142–170
   Google Scholar
• Benichou G., Takizawa P. A., McMillan M., Sercarz E. E. Allo-MHC peptides are recognized in a self context during graft rejection. 1990, Submitted
   Google Scholar
• Olson C. A., Williams L. C., McLaughin-Taylor E., McMillan M. Creation of H-2 class I epitopes using synthetic peptides: Recognition by alloreactive cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 1989; 86: 1031–1035
   Google Scholar
• Maryanski J. L., Verdini A. S., Weber P. C., Salemme F. R., Corradin G. Competitor analogs for defined T cell antigens: Peptides incorporating a putative binding motif and polyproline or polyglycine spacers. Cell 1990; 60: 63–72
   Google Scholar
• Adorini L., Muller S., Cardinaux F., Lehmann P. V., Falcioni F., Nagy Z. A. In vivo competition between self peptides and foreign antigens in T cell activation. Nature 1988; 334: 623–625
   PubMed Web of Science ®Google Scholar
• Singh V. K., Kalra H. K., Yamaki K., Abe T., Donoso L. A., Shinohara T. Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. J. Immunol. 1990; 144: 1282–1287
   PubMed Web of Science ®Google Scholar
• Gautam A. M., Glynn P. Competition between foreign and self proteins in antigen presentation. Ovalbumin can inhibit activation of myelin basic protein-specific T cells. J. Immunol. 1990; 144: 1177–1180
   PubMedGoogle Scholar
• Sakai K., Zamvil S. S., Mitchell D. J., Hodgkinson S., Rothbard D. B., Steinman L. Presentation of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. Proc. Natl. Acad. Sci. USA 1989; 86: 9470–9474
   PubMed Web of Science ®Google Scholar
• Vandenbark A. A., Hashim G., Offner H. Immunization with a T-cell receptor V gene peptide protects against experimental autoimmune encephalomyelitis. Nature 1989; 341: 541–544
   PubMed Web of Science ®Google Scholar
• Howell M. D., Winters S. T., Olee T., Powell H. C., Carlo D. J., Brostoff S. W. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989; 246: 668–670
   PubMed Web of Science ®Google Scholar
• Mazerolles F., Durandy A., Platier-Tonneau D., Charron D., Montagnier L., Auffray C., Fisher A. Immunosuppressive properties of synthetic peptides derived from CD4 and HLA-DR antigens. Cell 1988; 55: 497–504
   Google Scholar
• Janeway C. A. Autoimmune disease: Immunotherapy by peptides?. Nature 1989; 341: 482–483
   Google Scholar